We are live on ! Find out more
GPP

Great Point Partners Portfolio holdings

AUM $408M
1-Year Est. Return 318.81%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+318.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$640M
AUM Growth
+$66.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
49
New
Increased
Reduced
Closed

Top Buys

1
+$37.4M
2
+$24.9M
3
+$20M
4
FPRX
Five Prime Therapeutics, Inc.
FPRX
+$16.9M
5
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$14M

Top Sells

1
+$32.9M
2
+$17.3M
3
+$15M
4
LUMO
Lumos Pharma, Inc. Common Stock
LUMO
+$13.8M
5
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$13.5M

Sector Composition

1 Healthcare 88.08%
2 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$1.95M 0.31%
+722
27
$1.69M 0.26%
25,944
-194,845
28
$1.1M 0.17%
+500,000
29
$239K 0.04%
8,676
30
– –
-20,000
31
– –
-31,314
32
– –
-70,323
33
– –
0
34
– –
-5,930
35
– –
-200,000
36
– –
-331,085
37
– –
-300,000
38
– –
0
39
– –
-292,673
40
– –
-356,250
41
– –
-160,530
42
– –
-669,472
43
– –
-840,303
44
– –
-75,000
45
– –
-43,637
46
– –
-4,127,232
47
– –
-500,192
48
– –
-40,000
1
2